A randomised controlled pilot study comparing Mepitel® and SurfaSoft® on paediatric donor sites treated with Recell ®

Bibliographic Details
Main Authors: Campanella, S., Rapley, Pat, Ramelet, A.
Format: Journal Article
Published: Elsevier 2011
Online Access:http://hdl.handle.net/20.500.11937/26410
_version_ 1848751978383933440
author Campanella, S.
Rapley, Pat
Ramelet, A.
author_facet Campanella, S.
Rapley, Pat
Ramelet, A.
author_sort Campanella, S.
building Curtin Institutional Repository
collection Online Access
first_indexed 2025-11-14T08:01:19Z
format Journal Article
id curtin-20.500.11937-26410
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T08:01:19Z
publishDate 2011
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-264102017-09-13T15:25:37Z A randomised controlled pilot study comparing Mepitel® and SurfaSoft® on paediatric donor sites treated with Recell ® Campanella, S. Rapley, Pat Ramelet, A. 2011 Journal Article http://hdl.handle.net/20.500.11937/26410 10.1016/j.burns.2011.04.019 Elsevier restricted
spellingShingle Campanella, S.
Rapley, Pat
Ramelet, A.
A randomised controlled pilot study comparing Mepitel® and SurfaSoft® on paediatric donor sites treated with Recell ®
title A randomised controlled pilot study comparing Mepitel® and SurfaSoft® on paediatric donor sites treated with Recell ®
title_full A randomised controlled pilot study comparing Mepitel® and SurfaSoft® on paediatric donor sites treated with Recell ®
title_fullStr A randomised controlled pilot study comparing Mepitel® and SurfaSoft® on paediatric donor sites treated with Recell ®
title_full_unstemmed A randomised controlled pilot study comparing Mepitel® and SurfaSoft® on paediatric donor sites treated with Recell ®
title_short A randomised controlled pilot study comparing Mepitel® and SurfaSoft® on paediatric donor sites treated with Recell ®
title_sort randomised controlled pilot study comparing mepitel® and surfasoft® on paediatric donor sites treated with recell ®
url http://hdl.handle.net/20.500.11937/26410